Target intelligence / Profile preview

POMGNT2 antisense RNA 1 (POMGNT2-AS1)

Target
POMGNT2-AS1
Molecular classification
Long non-coding RNA (lncRNA), Antisense RNA
01

Overview

POMGNT2 antisense RNA 1 (POMGNT2-AS1) is a long non-coding RNA identified as an antisense transcript at the POMGNT2 gene locus. In general, antisense RNAs regulate gene expression—often by interacting with the sense (protein-coding) transcript either pre- or post-transcriptionally. Their biological impact can include modulation of chromatin structure, transcription, or mRNA stability and translation, typically in a locus-specific (cis) manner. However, for POMGNT2-AS1, no detailed functional data or disease relevance is currently documented. It is not a protein target (enzyme, receptor, transporter, etc.), but a regulatory RNA likely involved in modulating expression of the POMGNT2 gene or nearby loci. The functional implications of POMGNT2-AS1 itself have not been specifically characterized; most information about antisense RNAs comes from studies of the general class. POMGNT2 (the sense gene) is a protein-coding gene encoding a glycosyltransferase implicated in muscular dystrophies, but POMGNT2-AS1 refers solely to its antisense RNA, which behaves as a non-coding regulatory molecule.

02

Biological functions

Regulation of gene expression

Beyond the preview

Go deeper on POMGNT2 antisense RNA 1 (POMGNT2-AS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on POMGNT2 antisense RNA 1 (POMGNT2-AS1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call